Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE DU SOLEIL KAYTANDJIAN : revenue, balance sheet and financial ratios

SELARL PHARMACIE DU SOLEIL KAYTANDJIAN is a French company founded 19 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BEAUSOLEIL (06240), this company of category PME shows in 2024 a net income negative of -45 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DU SOLEIL KAYTANDJIAN (SIREN 492838982)
Indicator 2024 2023 2022 2021 2020 2019
Revenue N/C N/C N/C N/C N/C N/C
Net income -44 735 € 182 352 € 696 573 € 401 464 € 276 765 € 271 990 €
EBITDA N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SELARL PHARMACIE DU SOLEIL KAYTANDJIAN records a net loss of 45 k€. This deficit will reduce equity on the balance sheet.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-44 735 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 36%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 66%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

36.037%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

65.62%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

13.9%

Solvency indicators evolution
SELARL PHARMACIE DU SOLEIL KAYTANDJIAN

Sector positioning

Debt ratio
36.04 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good

In 2024, the debt ratio of SELARL PHARMACIE DU SOLEI... (36.04) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
65.62% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good +12 pts over 3 years

In 2024, the financial autonomy of SELARL PHARMACIE DU SOLEI... (65.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 402.10. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

402.104

Liquidity indicators evolution
SELARL PHARMACIE DU SOLEIL KAYTANDJIAN

Sector positioning

Liquidity ratio
402.1 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent +18 pts over 3 years

In 2024, the liquidity ratio of SELARL PHARMACIE DU SOLEI... (402.10) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of SELARL PHARMACIE DU SOLEIL KAYTANDJIAN in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DU SOLEIL KAYTANDJIAN with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DU SOLEIL KAYTANDJIAN

What is the revenue of SELARL PHARMACIE DU SOLEIL KAYTANDJIAN ?

The revenue of SELARL PHARMACIE DU SOLEIL KAYTANDJIAN is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE DU SOLEIL KAYTANDJIAN profitable?

SELARL PHARMACIE DU SOLEIL KAYTANDJIAN recorded a net loss in 2024.

Where is the headquarters of SELARL PHARMACIE DU SOLEIL KAYTANDJIAN ?

The headquarters of SELARL PHARMACIE DU SOLEIL KAYTANDJIAN is located in BEAUSOLEIL (06240), in the department Alpes-Maritimes.

Where to find the tax return of SELARL PHARMACIE DU SOLEIL KAYTANDJIAN ?

The tax return of SELARL PHARMACIE DU SOLEIL KAYTANDJIAN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DU SOLEIL KAYTANDJIAN operate?

SELARL PHARMACIE DU SOLEIL KAYTANDJIAN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.